封面
市場調查報告書
商品編碼
2058356

臨床前單一器官灌注系統市場:按類型、應用和地區分類

Preclinical Isolated Organ Perfusion System Market, By Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年臨床前單一器官灌注系統的市場規模估計為5.668億美元,預計到2033年將達到7.54億美元。預計從2026年到2033年,其複合年成長率將達到4.1%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 5.668億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 4.10% 2033年市場規模預測: 7.54億美元

單一器官灌注是一種研究各個器官生理和功能的絕佳技術。它能夠對器官本身及其藥理反應進行詳細檢查。單一器官灌注有助於了解各器官的血液動力學、不同灌注液的作用、藥物毒性。

市場動態

器官移植數量的不斷增加預計將推動全球臨床前單一器官灌注系統市場的成長。例如,根據非營利科學教育組織「器官共享聯合網路」(UNOS)發表的報導,2016年美國共進行了33,600例器官移植手術,另有1,14,756名患者在等待移植。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新藥上市和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的關鍵見解。
  • 本研究根據以下參數對全球臨床前單器官灌注系統市場的主要參與者進行了分析:公司概況、財務績效、產品系列、市場地位、分銷策略、關鍵發展、策略和未來計劃。
  • 透過利用本報告中提出的見解,企業行銷負責人和經營團隊將能夠就未來的藥物上市、藥物類別升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球臨床前單器官灌注系統市場」報告針對產業內的各種相關人員,包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
  • 透過利用全球臨床前單一器官灌注系統市場分析中使用的各種策略矩陣,相關人員可以更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 管道分析
  • 救贖方案
  • 流行病學
  • PEST分析
  • 監管趨勢
  • 新產品發布
  • 合作關係與協議
  • 市場趨勢

第4章 全球臨床前單一器官灌注系統市場:依類型分類,2021-2033年

  • 隔離式心臟灌注系統
  • 分離式腹腔器官灌注系統
  • 肺分離灌注系統
  • 其他

第5章 全球臨床前單一器官灌注系統市場:依應用領域分類,2021-2033年

  • 工業研究機構和合約研究組織
  • 學術和政府研究機構

第6章 全球臨床前單一器官灌流系統市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 中非
    • 北非

第7章 競爭情勢

  • 熱圖分析
  • 市佔率分析
    • World Precision Instruments Inc.
    • Radnoti LLC
    • MDE GmbH
    • Harvard Bioscience Inc.
    • emka TECHNOLOGIES SAS
    • Danish Myo Technology AS
    • ADInstruments Pty Ltd.
    • Experimetria Ltd.

第8章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4351

Preclinical Isolated Organ Perfusion System Market is estimated to be valued at USD 566.8 Mn in 2026 and is expected to reach USD 754.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 566.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 4.10% 2033 Value Projection: USD 754.0 Mn

Isolated organ perfusion is an excellent tool for investigating the physiology and function of a variety of individual organs. It enables exploration of organs and their pharmacologic reactions. Isolated perfusion helps to understand the hemodynamics, effects of various perfusates, and toxicity of drugs on individual organs.

Market Dynamics

An increasing number of organ transplants is expected to drive the global preclinical isolated organ perfusion system market growth. For instance, according to an article published by the United Network for Organ Sharing, a non-profit, scientific and educational organization, in 2016, 33,600 organ transplants were performed in the U.S. and 114,756 patients were on the waiting list.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preclinical isolated organ perfusion system market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are World Precision Instruments Inc., Radnoti LLC, MDE GmbH, Harvard Bioscience Inc., emka TECHNOLOGIES S.A.S., Danish Myo Technology AS, ADInstruments Pty Ltd. and Experimetria Ltd. among others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global preclinical isolated organ perfusion system market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical isolated organ perfusion system market.

Market Segmentation

  • By Type (Revenue, USD Mn, 2021-2033)
    • Isolated Heart Perfusion Systems
    • Isolated Abdominal Organ Perfusion Systems
    • Isolated Lung Perfusion Systems
    • Others
  • By Application (Revenue, USD Mn, 2021-2033)
    • Industrial Laboratories and CROs
    • Academic and Government Research Institutes
  • By Region (Revenue, USD Mn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Competitive Landscape
    • World Precision Instruments Inc.
    • Radnoti LLC
    • MDE GmbH
    • Harvard Bioscience Inc.
    • emka TECHNOLOGIES S.A.S.
    • Danish Myo Technology AS
    • ADInstruments Pty Ltd.
    • Experimetria Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Preclinical Isolated Organ Perfusion System Market, By Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Isolated Heart Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Isolated Abdominal Organ Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Isolated Lung Perfusion Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Preclinical Isolated Organ Perfusion System Market, By Application, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Industrial Laboratories and CROs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Academic and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Preclinical Isolated Organ Perfusion System Market, By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022 - 2033
  • North America
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, (US$ Mn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • World Precision Instruments Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Radnoti LLC
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • MDE GmbH
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Harvard Bioscience Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • emka TECHNOLOGIES S.A.S.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Danish Myo Technology AS
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • ADInstruments Pty Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Experimetria Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact